1832 Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $209M | Buy |
|
|||||
|
2025
Q2 | $72.8M | Buy |
|
|||||
|
2025
Q1 | $38.9M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $132K | Hold |
|
|||||
|
2024
Q1 | $81.5K | Hold |
|
|||||
|
2023
Q4 | $104K | Hold |
|
|||||
|
2023
Q3 | $96.5K | Hold |
|
|||||
|
2023
Q2 | $104K | Sell |
|
|||||
|
2023
Q1 | $4.56M | Sell |
|
|||||
|
2022
Q4 | $93M | Buy |
|
|||||
|
2022
Q3 | $77.5M | Buy |
|
|||||
|
2022
Q2 | $79K | Hold |
|
|||||
|
2022
Q1 | $88K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2.29M | Buy |
|